Sign inGet started

Salzman Amber

Insider CIK 1674536 · ADVM President and COO, Director · AKCA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AKCA AKCEA THERAPEUTICS, INC. D To issuer deriv2020-10-122020-10-1326,400$2.01 $53.1K0SEC↗
AKCA AKCEA THERAPEUTICS, INC. D To issuer deriv2020-10-122020-10-1353,000$0.21 $11.1K0SEC↗
AKCA AKCEA THERAPEUTICS, INC. A Award deriv2020-04-132020-04-1526,400— $026,400SEC↗
AKCA AKCEA THERAPEUTICS, INC. A Award deriv2020-02-122020-02-1353,000— $053,000SEC↗
ADVM Adverum Biotechnologies, I A Award deriv2018-02-152018-02-20478,000— $0478,000SEC↗
ADVM Adverum Biotechnologies, I A Award deriv2017-02-092017-02-13378,000— $0378,000SEC↗
ADVM Adverum Biotechnologies, I A Award2017-02-092017-02-13262,000— $0891,766SEC↗
ADVM Adverum Biotechnologies, I A Award deriv2016-05-112016-05-13377,890— $0377,890SEC↗
ADVM Adverum Biotechnologies, I A Award deriv2016-05-112016-05-13218,000— $0218,000SEC↗
ADVM Adverum Biotechnologies, I A Award2016-05-112016-05-13629,766— $0629,766SEC↗